← back to search

Marnix H. Geukes Foppen

The Netherlands Cancer Institute ·
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Melanoma and MAPK Pathways, and Immunotherapy and Immune Responses.
h-index
18
citations
5,650
works
29
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
New England Journal of Medicine 2022cited by 516position: middledoi
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
Journal for ImmunoTherapy of Cancer 2020cited by 194position: middledoi
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis
Cancer Immunology Immunotherapy 2019cited by 36position: middledoi
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma
OncoImmunology 2016cited by 146position: middledoi
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Science 2015cited by 2,954position: middledoi
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Nature Communications 2014cited by 633position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christian U. Blank · Dutch Cancer Society5 papers (2014–2020)John B.A.G. Haanen · Nikki-Universal (Japan)3 papers (2014–2020)Simone M. Goldinger · The University of Queensland2 papers (2015–2019)Bastian Schilling · Goethe University Frankfurt2 papers (2015–2019)Ralf Gutzmer · University of Duisburg-Essen2 papers (2015–2019)Dirk Schadendorf · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori2 papers (2015–2019)Jessica C. Hassel · Praxis für Hämatologie und Onkologie2 papers (2015–2019)Reinhard Dummer · Kantonsspital Aarau2 papers (2015–2016)Benjamin Weide · University Children's Hospital Tübingen2 papers (2015–2019)Ton N. Schumacher · Oncode Institute1 papers (2020–2020)Henk Mallo · The Netherlands Cancer Institute1 papers (2020–2020)Claus Garbe · STZ eyetrial1 papers (2019–2019)— · 1 papers (2016–2016)Colin R. Goding · Centre for Human Genetics1 papers (2014–2014)— · 1 papers (2014–2014)— · 1 papers (2014–2014)Jochen Utikal · German Cancer Research Center1 papers (2015–2015)— · 1 papers (2020–2020)Pia Kvistborg · The Netherlands Cancer Institute1 papers (2020–2020)— · 1 papers (2020–2020)